AseBio and CSIC have signed a new framework agreement to enhance collaboration between biotechnology companies and researchers. Their goal is to advance scientific research, innovation, and...
The Spanish biotechnology sector, detailed in the AseBio 2023 Report, generated over €16.6 billion in 2022, 1.5% of GDP, and contributed 162,845 jobs. Private financing reached...
In 2023, Spanish biotech companies secured 228 million euros in private financing, a 37% increase from 2022. This was announced at the AseBio Investor Day, organized...
In the Spanish biotech sector, 60% of employees are women, yet only 37% of leadership positions in companies are held by women, according to a report...
The path laid out by general pharmaceutical legislation, according to the Asebio study's conclusions, makes it less likely to achieve objectives related to, for example, rare...
Spanish biotech companies maintain their leading position in the industrial sector in science with the highest percentage of researchers. The research workplaces Spain in the ninth position...